secwatch.observer — SEC 8-K summary
======================================

Issuer:     MUSTANG BIO, INC. (MBIO)
CIK:        0001680048
Form:       8-K
Filed at:   2024-03-29T23:59:59+00:00
Accession:  0001104659-24-041199
Event type: regulatory
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Mustang Bio provides CFIUS update on facility sale to uBriGene; investigation due by May 13, 2024
--------------------------------------------------------------------------------

- Transaction involves sale of Worcester cell processing facility and manufacturing assets to uBriGene.
- CFIUS review entered a second 45-day investigation period ending May 13, 2024.
- CFIUS clearance not a condition to closing but may affect timing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680048/000110465924041199/0001104659-24-041199-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680048/000110465924041199/tm2410237d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-041199

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer